KR20210143254A - 마취 조성물 및 안구의 마취 방법 - Google Patents

마취 조성물 및 안구의 마취 방법 Download PDF

Info

Publication number
KR20210143254A
KR20210143254A KR1020217034148A KR20217034148A KR20210143254A KR 20210143254 A KR20210143254 A KR 20210143254A KR 1020217034148 A KR1020217034148 A KR 1020217034148A KR 20217034148 A KR20217034148 A KR 20217034148A KR 20210143254 A KR20210143254 A KR 20210143254A
Authority
KR
South Korea
Prior art keywords
composition
articaine
mannitol
borate
complex
Prior art date
Application number
KR1020217034148A
Other languages
English (en)
Korean (ko)
Inventor
마틴 우람
Original Assignee
마틴 우람
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2019/024239 external-priority patent/WO2019191200A1/fr
Application filed by 마틴 우람 filed Critical 마틴 우람
Publication of KR20210143254A publication Critical patent/KR20210143254A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020217034148A 2019-03-26 2020-03-16 마취 조성물 및 안구의 마취 방법 KR20210143254A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962824207P 2019-03-26 2019-03-26
US62/824,207 2019-03-26
USPCT/US2019/024239 2019-03-27
PCT/US2019/024239 WO2019191200A1 (fr) 2018-03-27 2019-03-27 Procédé et formulation pour réaliser une anesthésie d'aspect interne de paroi oculaire par application topique
US16/811,798 US11096922B2 (en) 2018-03-27 2020-03-06 Anesthetic composition and method of anesthetizing the eye
US16/811,798 2020-03-06
PCT/US2020/022915 WO2020197816A1 (fr) 2019-03-26 2020-03-16 Composition anesthésique et procédé d'anesthésie de l'œil

Publications (1)

Publication Number Publication Date
KR20210143254A true KR20210143254A (ko) 2021-11-26

Family

ID=72609654

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217034148A KR20210143254A (ko) 2019-03-26 2020-03-16 마취 조성물 및 안구의 마취 방법

Country Status (11)

Country Link
EP (1) EP3946311A4 (fr)
JP (1) JP2022527621A (fr)
KR (1) KR20210143254A (fr)
CN (1) CN114072139A (fr)
AU (1) AU2020245203A1 (fr)
BR (1) BR112021019039A2 (fr)
CA (1) CA3134531A1 (fr)
IL (1) IL286624A (fr)
MX (1) MX2021011589A (fr)
SG (1) SG11202110423UA (fr)
WO (1) WO2020197816A1 (fr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0639070B2 (fr) * 1992-05-06 2010-09-08 Alcon Laboratories, Inc. Utilisation de complexes borate-polyol dans des compositions ophtalmiques
JP4436131B2 (ja) * 2001-11-21 2010-03-24 イオルテク ヒアルロン酸を安定化させる組成物
CN101695488B (zh) * 2009-11-05 2012-05-02 蚌埠丰原涂山制药有限公司 复方阿替卡因注射用冻干制剂及其制备方法
CN101721407B (zh) * 2009-11-23 2013-04-10 蚌埠丰原涂山制药有限公司 复方盐酸阿替卡因注射液及其制备方法
FR2968996B1 (fr) * 2010-12-17 2013-04-12 Anteis Sa Formulation aqueuse injectable sterile utilisee en ophtalmologie
FR3036035B1 (fr) * 2015-05-11 2018-10-05 Laboratoires Vivacy Compositions comprenant au moins un polyol et au moins un anesthesique
US20180250313A1 (en) * 2015-09-08 2018-09-06 Viewpoint Therapeutics, Inc. Compounds and formulations for treating ophthalmic diseases
WO2018220283A1 (fr) * 2017-05-29 2018-12-06 Kh Medtech Sarl Composition injectable sterile contenant de l'acide hyaluronique reticule et de l'articaine

Also Published As

Publication number Publication date
AU2020245203A1 (en) 2021-11-11
SG11202110423UA (en) 2021-10-28
EP3946311A4 (fr) 2022-12-28
MX2021011589A (es) 2021-12-15
JP2022527621A (ja) 2022-06-02
WO2020197816A1 (fr) 2020-10-01
CA3134531A1 (fr) 2020-10-01
IL286624A (en) 2021-10-31
EP3946311A1 (fr) 2022-02-09
BR112021019039A2 (pt) 2021-11-30
CN114072139A (zh) 2022-02-18

Similar Documents

Publication Publication Date Title
US20230181497A1 (en) Ketorolac tromethamine compositions for treating or preventing ocular pain
KR101809713B1 (ko) 방부제 없는 프로스타글란딘계 비점성 용액의 고분자 전달 시스템
KR20120112537A (ko) 무자극성 안과용 포비돈-요오드 조성물
CN103747786A (zh) 比马前列素和溴莫尼定的固定剂量组合
AU2021221401B2 (en) Stable peptide compositions
US20240041824A1 (en) Anesthetic composition and method of anesthetizing the eye
JP6934581B2 (ja) エピナスチン又はその塩を含有する水性医薬組成物
EP4029493A1 (fr) Composition ophtalmique en nanoémulsion comprenant de la cyclosporine et du menthol, et son procédé de préparation
JP2017525758A (ja) リファマイシンの眼科用組成物およびその使用
JP3502574B2 (ja) 眼感染症治療用眼軟膏剤
KR20210143254A (ko) 마취 조성물 및 안구의 마취 방법
RU2812900C2 (ru) Анестезирующая композиция и способ анестезирования глаза
CA3088185C (fr) Compositions de suspension d'inhibiteurs multi-cibles
WO2018123945A1 (fr) Préparation d'une forme dépôt comprenant du tafluprost et un ester d'acide citrique
US20050130951A1 (en) Superoxide dismutase mimics for the treatment of optic nerve and retinal damage
JP6963651B2 (ja) エピナスチン又はその塩を含有する水性組成物
AU2017235979A1 (en) Non-irritating ophthalmic povidone-iodine compositions
JP5299449B2 (ja) 外用剤組成物
WO2024135837A1 (fr) Composition aqueuse contenant de l'épinastine pour améliorer la transférabilité à un tissu et l'effet conservateur
EA004050B1 (ru) Способ изготовления состава местных бета-блокаторов улучшенного действия